Neuroprotective mechanisms and translational potential of therapeutic hypothermia in the treatment of ischemic stroke

Neuroprotective mechanisms and translational potential of therapeutic hypothermia in the treatment of ischemic stroke

Stroke is a leading cause of disability and death, yet effective treatments for acute stroke has been very limited. Thus far, tissue plasminogen activator has been the only FDA-approved drug for thrombolytic treatment of ischemic stroke patients, yet its application is only applicable to less than 4...

Full description

Bibliographic Details
Main Authors: Jin Hwan Lee, James Zhang, Shan Ping Yu
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Neural Regeneration Research
Subjects:
stroke; therapeutic hypothermia; drug-induced hypothermia; ischemia; cell death; inflammation
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2017;volume=12;issue=3;spage=341;epage=350;aulast=Lee

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2017;volume=12;issue=3;spage=341;epage=350;aulast=Lee

Similar Items